Literature DB >> 15731249

Stable secondary structure near the nicking site for adeno-associated virus type 2 Rep proteins on human chromosome 19.

Ming Y Jang1, Orlando H Yarborough, Gary B Conyers, Peter McPhie, Roland A Owens.   

Abstract

Adeno-associated virus serotype 2 (AAV-2) can preferentially integrate its DNA into a 4-kb region of human chromosome 19, designated AAVS1. The nicking activity of AAV-2's Rep68 or Rep78 proteins is essential for preferential integration. These proteins nick at the viral origin of DNA replication and at a similar site within AAVS1. The current nicking model suggests that the strand containing the nicking site is separated from its complementary strand prior to nicking. In AAV serotypes 1 through 6, the nicking site is flanked by a sequence that is predicted to form a stem-loop with standard Watson-Crick base pairing. The region flanking the nicking site in AAVS1 (5'-GGCGGCGGT/TGGGGCTCG-3' [the slash indicates the nicking site]) lacks extensive potential for Watson-Crick base pairing. We therefore performed an empirical search for a stable secondary structure. By comparing the migration of radiolabeled oligonucleotides containing wild-type or mutated sequences from the AAVS1 nicking site to appropriate standards, on native and denaturing polyacrylamide gels, we have found evidence that this region forms a stable secondary structure. Further confirmation was provided by circular dichroism analyses. We identified six bases that appear to be important in forming this putative secondary structure. Mutation of five of these bases, within the context of a double-stranded nicking substrate, reduces the ability of the substrate to be nicked by Rep78 in vitro. Four of these five bases are outside the previously recognized GTTGG nicking site motif and include parts of the CTC motif that has been demonstrated to be important for integration targeting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731249      PMCID: PMC1075745          DOI: 10.1128/JVI.79.6.3544-3556.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

Review 1.  The physical and chemical properties of nucleic acids.

Authors:  G Felsenfeld; H T Miles
Journal:  Annu Rev Biochem       Date:  1967       Impact factor: 23.643

2.  Circular dichroism of DNA.

Authors:  W B Gratzer; L R Hill; R J Owen
Journal:  Eur J Biochem       Date:  1970-08

3.  Nucleotide sequence and organization of the adeno-associated virus 2 genome.

Authors:  A Srivastava; E W Lusby; K I Berns
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

4.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Evidence for two nucleotide sequence orientations within the terminal repetition of adeno-associated virus DNA.

Authors:  I S Spear; K H Fife; W W Hauswirth; C J Jones; K I Berns
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

6.  In vitro resolution of covalently joined AAV chromosome ends.

Authors:  R O Snyder; R J Samulski; N Muzyczka
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

7.  The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity.

Authors:  D S Im; N Muzyczka
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

8.  Site-specific integration by adeno-associated virus.

Authors:  R M Kotin; M Siniscalco; R J Samulski; X D Zhu; L Hunter; C A Laughlin; S McLaughlin; N Muzyczka; M Rocchi; K I Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

9.  Organization of adeno-associated virus DNA in latently infected Detroit 6 cells.

Authors:  R M Kotin; K I Berns
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

10.  Requirements for adeno-associated virus-derived non-viral vectors to achieve stable and site-specific integration of plasmid DNA in liver carcinoma cells.

Authors:  Robin Steigerwald; Christian Rabe; Volker Schmitz; Ingo G Schmidt-Wolf; Michael Alt; Wolfgang H Caselmann
Journal:  Digestion       Date:  2003-08-29       Impact factor: 3.216

View more
  7 in total

1.  The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element.

Authors:  Achille François; Mickaël Guilbaud; Rafi Awedikian; Gilliane Chadeuf; Philippe Moullier; Anna Salvetti
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  The Adeno-Associated Virus Genome Packaging Puzzle.

Authors:  Chen Ling; Yuan Wang; Yuan Lu; Lina Wang; Giridhara R Jayandharan; George V Aslanidi; Baozheng Li; Binbin Cheng; Wenqin Ma; Thomas Lentz; Changquan Ling; Xiao Xiao; R Jude Samulski; Nicholas Muzyczka; Arun Srivastava
Journal:  J Mol Genet Med       Date:  2015-07-15

3.  Identification of cellular proteins that interact with the adeno-associated virus rep protein.

Authors:  Kevin Nash; Weijun Chen; Max Salganik; Nicholas Muzyczka
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

4.  Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome.

Authors:  Daniela Hüser; Andreas Gogol-Döring; Timo Lutter; Stefan Weger; Kerstin Winter; Eva-Maria Hammer; Toni Cathomen; Knut Reinert; Regine Heilbronn
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

5.  Substitution of adeno-associated virus Rep protein binding and nicking sites with human chromosome 19 sequences.

Authors:  Victor J McAlister; Roland A Owens
Journal:  Virol J       Date:  2010-09-08       Impact factor: 4.099

Review 6.  Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics.

Authors:  Dinshaw J Patel; Anh Tuân Phan; Vitaly Kuryavyi
Journal:  Nucleic Acids Res       Date:  2007-10-02       Impact factor: 16.971

7.  Formation of a unique cluster of G-quadruplex structures in the HIV-1 Nef coding region: implications for antiviral activity.

Authors:  Rosalba Perrone; Matteo Nadai; Jerrod A Poe; Ilaria Frasson; Manlio Palumbo; Giorgio Palù; Thomas E Smithgall; Sara N Richter
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.